Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1246 AL 1260

Transducer-based evaluation of tremor

Haubenberger D, Abbruzzese G, Bain PG, Bajaj N, Benito-León J, Bhatia KP, Deuschl G, Forjaz MJ, Hallett M, Louis ED, Lyons KE, Mestre TA, Raethjen J, Stamelou M, Tan EK, Testa CM, Elble RJ.

Mov Disord. 2016 Sep;31(9):1327-36. doi: 10.1002/mds.26671. Epub 2016 Jun 6.

A clinical view on the development of technology-based tools in managing Parkinson's disease

Maetzler W, Klucken J, Horne M.

Mov Disord. 2016 Sep;31(9):1263-71. doi: 10.1002/mds.26673. Epub 2016 Jun 7.

Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community

Mahlknecht P, Gasperi A, Willeit P, Kiechl S, Stockner H, Willeit J, Rungger G, Sawires M, Nocker M, Rastner V, Mair KJ, Hotter A, Poewe W, Seppi K.

Mov Disord. 2016 Sep;31(9):1405-8. doi: 10.1002/mds.26674. Epub 2016 Jun 6.

The effectiveness of physiotherapy treatment on balance dysfunction and postural instability in persons with Parkinson's disease: a systematic review and meta-analysis

Yitayeh A, Teshome A.

BMC Sports Sci Med Rehabil. 2016 Jun 6;8:17. doi: 10.1186/s13102-016-0042-0. eCollection 2016.

[Parkinson's Disease at the Border Between Inpatient and Outpatient Care]

Buhmann C, Bass H, Hahne M, Jost W, Redecker C, Schwarz M, Woitalla D.

Fortschr Neurol Psychiatr. 2016 Jul;84 Suppl 1:S36-40. doi: 10.1055/s-0042-103325. Epub 2016 Jun 8.

[The Geriatric Patient with Parkinson's Disease - a Neurological Challenge]

Lingor P, Csoti I, Koschel J, Schrader C, Winkler C, Wolz M, Reichmann H.

Fortschr Neurol Psychiatr. 2016 Jul;84 Suppl 1:S41-7. doi: 10.1055/s-0042-103585. Epub 2016 Jun 8.

[Wearable Technique for the Assessment of Parkinson Symptoms: What's the Future?]

Maetzler W, Krüger R, Müller T, Oertel W, Urban P, Warnecke T, Klucken J.

Fortschr Neurol Psychiatr. 2016 Jul;84 Suppl 1:S48-51. doi: 10.1055/s-0042-102786. Epub 2016 Jun 8.

[Perioperative Management of PD Patients]

Reichmann H.

Fortschr Neurol Psychiatr. 2016 Jul;84 Suppl 1:S14-7. doi: 10.1055/s-0042-102454. Epub 2016 Jun 8.

Dopamine transporter mutant animals: a translational perspective

Efimova EV, Gainetdinov RR, Budygin EA, Sotnikova TD.

J Neurogenet. 2016 Mar;30(1):5-15. doi: 10.3109/01677063.2016.1144751.

Incretin-based therapy for type 2 diabetes mellitus is promising for treating neurodegenerative diseases

Li Y, Li L, Hölscher C.

Rev Neurosci. 2016 Oct 1;27(7):689-711. doi: 10.1515/revneuro-2016-0018.

[Dementia with motor and language disorders]

Frédéric A, Ghika J.

Rev Med Suisse. 2016 Apr 20;12(515):780-5.

Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study

Lizarraga KJ, Jagid JR, Luca CC.

J Neurol. 2016 Aug;263(8):1652-6. doi: 10.1007/s00415-016-8191-3. Epub 2016 Jun 8.

A Method for Automated Classification of Parkinson's Disease Diagnosis Using an Ensemble Average Propagator Template Brain Map Estimated from Diffusion MRI

Banerjee M, Okun MS, Vaillancourt DE, Vemuri BC.

PLoS One. 2016 Jun 9;11(6):e0155764. doi: 10.1371/journal.pone.0155764. eCollection 2016.

Myeloperoxidase as a Target for the Treatment of Inflammatory Syndromes: Mechanisms and Structure Activity Relationships of Inhibitors

Soubhye J, Aldib I, Delporte C, Prévost M, Dufrasne F, Antwerpen PV.

Curr Med Chem. 2016;23(35):3975-4008. doi: 10.2174/0929867323666160607111806.

Distribution of PSA-NCAM in normal, Alzheimer's and Parkinson's disease human brain

Murray HC, Low VF, Swanson ME, Dieriks BV, Turner C, Faull RL, Curtis MA.

Neuroscience. 2016 Aug 25;330:359-75. doi: 10.1016/j.neuroscience.2016.06.003. Epub 2016 Jun 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias